Navigation Links
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
Date:7/17/2012

ve European countries of the UK, France, Italy, Germany and Spain; and Japan.

Cancer is considered to be one of the most feared diseases, a cure for which has so far eluded researchers all over the world. However, new lines of therapeutics Vascular Endothelial Growth Factor (VEGF) inhibitors and Epidermal Growth Factor Receptor (EGFR) inhibitors are expected to make a significant impact on patient survival. However, progress in patient survival and other benefits are accompanied by premium prices, which has necessitated the creation of several agencies responsible for making decisions pertaining to pricing and reimbursement for cancer drugs in many countries of the world in order to contain costs related to cancer treatment. The report on "Pharmaceutical Pricing and Reimbursement in Oncology " delves into these recent changes in pricing and reimbursement mechanisms that are often targeted at expensive cancer drugs.

Scope

- Detailed study of the healthcare systems and roles of the key players in the respective pharmaceutical systems of the top seven countries of the world – the US, the UK, France, Germany, Italy, Spain and Japan.

- Analysis of the major pricing and reimbursement mechanisms in each country.

- Key trends that follow from the recent changes brought about in pricing and reimbursement mechanisms.

- Analysis of the possible major challenges brought about by the enactment of changes in the pricing and reimbursement scene in the countries covered in the report.

- Particular focus on pricing and reimbursement in oncology.

Reasons to buy

- Build an understanding of the oncology-related key pricing and reimbursement mechanisms in the top seven countries of the world.

- Optimize your investment through identification and understanding of the changes in oncology drugs' regulatory mechanisms and in the pricing and reimbursement scenario for the countries covered in the report.

<
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
2. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
5. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
6. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
7. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Ampio Pharmaceuticals Announces Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 The International ... of myeloma patients while working toward prevention and a ... (D-NY) for introducing a federal resolution (H. Res. 174) ... 2015 as "National Multiple Myeloma Awareness Month." ... myeloma worldwide, and more than 110,000 new cases are ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
(Date:3/26/2015)... 26, 2015 Huntington Memorial Hospital is the ... transcatheter aortic valve replacement (TAVR), a minimally invasive replacement ... new way to replace an aortic valve without a ... machine. The procedure is performed by a ... ( Alex) Durairaj , MD, interventional cardiologist and ...
Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... (Nasdaq: ENDP ) announced today topline results from ... against placebo in the treatment of patients with moderate to ... did not meet predetermined study end points. The company is ... path forward for the program. The study was ...
... and BRUSSELS, June 30, 2011 UCB and Harvard ... signing ceremony that took place in Boston last night ... of Belgium. (Photo: http://photos.prnewswire.com/prnh/20110630/NY28450 ) ... bridge between industry and academia, with Harvard scientists continuing ...
Cached Medicine Technology:Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... March 28, 2015 Genomic medicine experts ... mesothelioma, revealing, for the first time, key information for ... to read the newly posted story on the ... University of British Columbia, the British Columbia Cancer Agency, ... to reveal underlying molecular alterations and mutations that can ...
(Date:3/28/2015)... 2015 Lately the student-athlete experience ... changes and proposals around the NCAA. In a March ... collegiate student-athletes across a spectrum of universities and sports ... challenges. The special panel consists of athletes who have ... from football, track and field, baseball, and volleyball. They ...
(Date:3/28/2015)... La Mirada, CA (PRWEB) March 28, 2015 ... with ear, nose and throat disorders, are ... Tinnitus is a common issue which is characterized by ... ears. Affecting 1 in 5 people, tinnitus is a ... or disorder and while it is non-fatal, tinnitus can ...
Breaking Medicine News(10 mins):Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... Diabetic retinopathy is the most common disorder seen in diabetics. ... a person with diabetes develops diabetic retinopathy,// a major cause ... diabetes is responsible for 7 percent of legal blindness, making ... adults 22 to 70 years old. ,Researchers from the ...
... can block the death of brain cells in mice who ... (HD), which is a rare degenerative brain disorder //caused by ... may be one step closer to a treatment, according to ... treated with a bile acid known as tauroursodeoxycholic acid (TUDCA), ...
... shows people with diabetes who are in a happy ... unhappily married counterparts. Researchers from the State University of ... adults with diabetes who had been married for an ... insulin, were surveyed again two years after the initial ...
... the University in Boston, a person's degree of inhibition when ... tied to his or her likelihood of being overweight. The ... low-calorie foods--can help people who just can't seem to resist ... B. Roberts. The reasons why some people are able to ...
... According to a new study, it has been found ... as you age. Mental decline is not a specific part ... are typically living longer. The ability to know, think, learn ... of life and survival in older ages. Researchers from the ...
... cancer all over the world. More than 30,000 women ... breast cancer this year. Researchers now believe small family ... fueling this ever-growing epidemic.// ,Researchers from England ... information on breastfeeding and childbearing patterns. Together, the studies ...
Cached Medicine News:Health News:Stop and think before you eat 2Health News: Breastfeeding may decrease Breast Cancer Risk 2
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Intermittent catheter...
Intermittent catheter...
... dimension in vitreoretinal surgery. ,By using ... purified perfluoro-n-octane, you can greatly expand ... for managing retinal detachments complicated by ... trauma. , ,Certified to be >99.9 ...
Medicine Products: